Pharma’s Next AI Problem Is Authority – PharmTech.com

The pharmaceutical industry faces emerging challenges regarding the regulatory authority and validation of AI systems used in drug development and clinical decision-making. As AI adoption accelerates across pharma operations, stakeholders must establish clear guidelines for AI accountability, transparency, and oversight to ensure compliance with regulatory standards. The sector’s ability to build trust in AI-driven processes will be critical for widespread implementation and patient safety assurance.

Read Full Article →